Tags: antibody therapy, B cells, drug development, immunotherapy, monoclonal antibodiesBispecific AntibodiesDLBCLTherapeutic Potential
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | ||
| 2 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 10 days ago STAT+: Ocular Therapeutix moves in the right direction, and Alnylam tries to calm some nerves - 9 months ago | |
| 3 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 4 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago | |
| 5 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | ||
| 6 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - about 2 months ago Astellas’ science chief on the leap into new technologies - 9 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - about 1 year ago | |
| 7 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 8 | PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom | ||
| 9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 10 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California |